United States Pharmaceuticals

Innoviva Inc (INVA)

Track

Innoviva Inc. experienced significant insider activity in early March 2025, when Alexander J. Denner executed multiple sell transactions totaling over 1.6 million shares. These divestments represent the most recent recorded movements, occurring well beyond the three-month window. Prior to this period, historical data shows various buying and selling patterns by company leadership.
Ticker: INVA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Innoviva Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.8
DENNER ALEXANDER J Large shareholder
Transaction date
Sale
Price
496.87
Quantity 95,779 +1.3%
Value US$4,252,001
2.8
DENNER ALEXANDER J Large shareholder
Transaction date
Sale
Price
122.57
Quantity 84,157 -0.5%
Value US$2,308,290
2.8
DENNER ALEXANDER J Large shareholder
Transaction date
Sale
Price
141.83
Quantity 59,108 +9.9%
Value US$1,180,684
2.6
Zhen Marianne Chief Accounting Officer Officer
Transaction date
Sale
Price
13.97
Quantity 5,405 -11.9%
Value US$75,508
2.6
Zhen Marianne Chief Accounting Officer Officer
Transaction date
Sale
Price
14.01
Quantity 5,589 -10.9%
Value US$78,302
2.8
DENNER ALEXANDER J Large shareholder
Transaction date
Purchase
Price
13.13
Quantity 62,000 +0.9%
Value US$814,196
2.8
DENNER ALEXANDER J Large shareholder
Transaction date
Purchase
Price
13.05
Quantity 8,000 +0.1%
Value US$104,384
2.8
DENNER ALEXANDER J Large shareholder
Transaction date
Purchase
Price
13.04
Quantity 7,000 +0.1%
Value US$91,297
2.8
DENNER ALEXANDER J Large shareholder
Transaction date
Purchase
Price
13.01
Quantity 120,000 +1.7%
Value US$1,560,648
2.8
DENNER ALEXANDER J Large shareholder
Transaction date
Purchase
Price
13.12
Quantity 30,000 +0.4%
Value US$393,729
2.8
DENNER ALEXANDER J Large shareholder
Transaction date
Purchase
Price
13.09
Quantity 50,000 +0.7%
Value US$654,330
2.8
DENNER ALEXANDER J Large shareholder
Transaction date
Purchase
Price
13.05
Quantity 10,000 +0.1%
Value US$130,538
2.8
DENNER ALEXANDER J Large shareholder
Transaction date
Purchase
Price
13.07
Quantity 50,000 +0.7%
Value US$653,690
2.8
DENNER ALEXANDER J Large shareholder
Transaction date
Purchase
Price
12.34
Quantity 290,000 +4.4%
Value US$3,577,411
Raifeld Pavel Chief Executive Officer Officer
Transaction date
Planned purchase
Price
10.87
Quantity 3,000 +44.1%
Value US$32,603
2.9
Bickerstaff George Non-Executive Director
Transaction date
Purchase
Price
13.46
Quantity 10,000 +8.7%
Value US$134,619
2.9
Bickerstaff George Non-Executive Director
Transaction date
Purchase
Price
12.97
Quantity 10,000 +9.6%
Value US$129,670
2.3
GLAXOSMITHKLINE PLC Large shareholder
Transaction date
Sale
Price
12.25
Quantity 32,005,260 -100.0%
Value US$392,064,435
2.6
Zhen Marianne Chief Accounting Officer Officer
Transaction date
Sale
Price
14.78
Quantity 2,954 -11.9%
Value US$43,660
2.9
Bickerstaff George Non-Executive Director
Transaction date
Purchase
Price
15.90
Quantity 15,000 +38.7%
Value US$238,500
2.6
Zhen Marianne Chief Accounting Officer Officer
Transaction date
Sale
Price
16.00
Quantity 5,617 -23.1%
Value US$89,872
2.9
Bickerstaff George Non-Executive Director
Transaction date
Purchase
Price
14.90
Quantity 10,000 +34.8%
Value US$148,958
1.5
HULME GEOFFREY Interim PEO Officer
Transaction date
Purchase
Price
14.80
Quantity 7,000 +inf%
Value US$103,600
ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer Officer
Transaction date
Planned sale
Price
14.11
Quantity 8,000 -2.7%
Value US$112,840
Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. Officer
Transaction date
Sale
Price
14.12
Quantity 8,504 -3.3%
Value US$120,080
ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer Officer
Transaction date
Planned sale
Price
14.40
Quantity 8,000 -2.6%
Value US$115,202
dEsparbes Eric SVP and CFO Officer
Transaction date
Planned sale
Price
14.40
Quantity 5,808 -1.5%
Value US$83,623
Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. Officer
Transaction date
Planned sale
Price
16.60
Quantity 9,890 -5.0%
Value US$164,148
ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer Officer
Transaction date
Planned sale
Price
16.51
Quantity 8,000 -3.3%
Value US$132,100
dEsparbes Eric Interim PEO, SVP and CFO Officer
Transaction date
Planned sale
Price
16.52
Quantity 5,378 -1.8%
Value US$88,825
Aguiar Michael W President & Chief Exec Officer Executive Director
Transaction date
Sale
Price
13.13
Quantity 12,022 -1.2%
Value US$157,791
Witek Theodore J. Jr. Sr. VP & Chief Scientific Off.
Transaction date
Planned sale
Price
13.29
Quantity 13,000 -5.7%
Value US$172,795
ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer
Transaction date
Planned sale
Price
13.26
Quantity 5,215 -2.0%
Value US$69,145
dEsparbes Eric SVP and CFO
Transaction date
Planned sale
Price
13.31
Quantity 13,460 -4.0%
Value US$179,171
dEsparbes Eric SVP and CFO
Transaction date
Planned sale
Price
13.04
Quantity 1,825 -0.5%
Value US$23,798
dEsparbes Eric SVP and CFO
Transaction date
Planned sale
Price
12.20
Quantity 1,825 -0.5%
Value US$22,265
Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. Officer
Transaction date
Planned sale
Price
12.01
Quantity 7,815 -3.1%
Value US$93,858
dEsparbes Eric SVP and CFO Officer
Transaction date
Planned sale
Price
11.85
Quantity 1,825 -0.5%
Value US$21,626
dEsparbes Eric SVP and CFO Officer
Transaction date
Planned sale
Price
12.07
Quantity 1,825 -0.5%
Value US$22,028
WITEK THEODORE L JR Sr. VP & Chief Scientific Off. Officer
Transaction date
Planned sale
Price
10.84
Quantity 3,700 -2.4%
Value US$40,123
dEsparbes Eric SVP and CFO Officer
Transaction date
Planned sale
Price
10.89
Quantity 1,800 -0.8%
Value US$19,602
dEsparbes Eric SVP and CFO Officer
Transaction date
Planned sale
Price
11.77
Quantity 3,700 -1.5%
Value US$43,549
Tyree James L Non-Executive Director
Transaction date
Planned sale
Price
10.47
Quantity 813 -1.6%
Value US$8,512
WALTRIP WILLIAM H Non-Executive Director
Transaction date
Sale
Price
16.32
Quantity 16,313 -11.7%
Value US$266,228
LEE JUNNING Sr. VP, Technical Operations Officer
Transaction date
Sale
Price
22.50
Quantity 53,424 -16.8%
Value US$1,202,040
Shafer Bradford J Sr VP, Gen. Counsel, Secretary Officer
Transaction date
Sale
Price
22.30
Quantity 1,048 -0.2%
Value US$23,370
Shafer Bradford J Sr VP, Gen. Counsel, Secretary Officer
Transaction date
Sale
Price
22.12
Quantity 27,108 -5.7%
Value US$599,629
Shafer Bradford J Sr VP, Gen. Counsel, Secretary Officer
Transaction date
Planned sale
Price
37.23
Quantity 1,800 -0.5%
Value US$67,014
Shafer Bradford J Sr VP, Gen. Counsel, Secretary Officer
Transaction date
Planned sale
Price
36.72
Quantity 64,006 -16.3%
Value US$2,350,300
Mammen Mathai SVP, Research & Early Clin Dev Officer
Transaction date
Planned sale
Price
40.04
Quantity 4,600 -2.4%
Value US$184,184
Shafer Bradford J Sr VP, Gen. Counsel, Secretary Officer
Transaction date
Sale
Price
35.04
Quantity 31,038 -9.3%
Value US$1,087,572
Brinkley David L Head of Business Dev. Officer
Transaction date
Planned sale
Price
40.33
Quantity 16,129 -22.7%
Value US$650,483
Brinkley David L Head of Business Dev. Officer
Transaction date
Planned sale
Price
34.77
Quantity 16,129 -22.7%
Value US$560,805
Mammen Mathai SVP, Research & Early Clin Dev Officer
Transaction date
Planned sale
Price
34.34
Quantity 200 -0.1%
Value US$6,868
Brinkley David L Head of Business Dev. Officer
Transaction date
Planned sale
Price
34.35
Quantity 100 -0.2%
Value US$3,435
Brinkley David L Head of Business Dev. Officer
Transaction date
Planned sale
Price
33.76
Quantity 17,004 -23.6%
Value US$574,055
Aguiar Michael W Sr VP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
34.34
Quantity 10,100 -6.6%
Value US$346,834
Aguiar Michael W Sr VP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
33.77
Quantity 160,779 -51.3%
Value US$5,429,507
Winningham Rick E Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
34.32
Quantity 1,577 -0.2%
Value US$54,123
Winningham Rick E Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
33.64
Quantity 253,955 -26.0%
Value US$8,543,046
Mammen Mathai SVP, Research & Early Clin Dev Officer
Transaction date
Planned sale
Price
22.14
Quantity 7,000 -3.2%
Value US$154,980
Mammen Mathai SVP, Research & Early Clin Dev Officer
Transaction date
Planned sale
Price
22.53
Quantity 200 -0.1%
Value US$4,506
Aguiar Michael W Sr VP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
27.86
Quantity 2,861 -2.1%
Value US$79,707
Aguiar Michael W Sr VP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
27.24
Quantity 17,700 -11.6%
Value US$482,148
Aguiar Michael W Sr VP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
28.01
Quantity 4,121 -2.6%
Value US$115,429
Mammen Mathai SVP, Research & Early Clin Dev Officer
Transaction date
Planned sale
Price
26.15
Quantity 3,108 -1.4%
Value US$81,274
Aguiar Michael W Sr VP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
27.04
Quantity 60,000 -27.5%
Value US$1,622,400
Brinkley David L Head of Business Dev. Officer
Transaction date
Planned sale
Price
27.92
Quantity 123,917 -65.0%
Value US$3,459,763
Winningham Rick E Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
28.15
Quantity 36,200 -5.8%
Value US$1,019,030
Winningham Rick E Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.77
Quantity 39,549 -5.9%
Value US$1,098,276
Aguiar Michael W Sr VP, Chief Financial Officer Officer
Transaction date
Sale
Price
22.29
Quantity 20,000 -11.2%
Value US$445,800
GLAXOSMITHKLINE PLC Large shareholder
Transaction date
Purchase
Price
21.29
Quantity 10,000,000 +63.2%
Value US$212,887,000
DRAZAN JEFFREY M Non-Executive Director
Transaction date
Sale
Price
21.71
Quantity 8,586 -20.4%
Value US$186,402
Aguiar Michael W Sr VP, Chief Financial Officer Officer
Transaction date
Sale
Price
21.86
Quantity 10,000 -5.1%
Value US$218,600
Shafer Bradford J Sr VP, Gen. Counsel, Secretary Officer
Transaction date
Planned sale
Price
21.00
Quantity 20,000 -5.4%
Value US$420,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-06 2025-03-06 S Sale
2.8
DENNER ALEXANDER J
Large shareholder
95,779 +1.3%
496.87
US$4,252,001 		95,779 +1.3% 496.87 US$4,252,001
2025-03-06 2025-03-05 S Sale
2.8
DENNER ALEXANDER J
Large shareholder
84,157 -0.5%
122.57
US$2,308,290 		84,157 -0.5% 122.57 US$2,308,290
2025-03-06 2025-03-04 S Sale
2.8
DENNER ALEXANDER J
Large shareholder
59,108 +9.9%
141.83
US$1,180,684 		59,108 +9.9% 141.83 US$1,180,684
2023-11-17 2023-11-15 S Sale
2.6
Zhen Marianne

Chief Accounting Officer

Officer
5,405 -11.9%
13.97
US$75,508 		5,405 -11.9% 13.97 US$75,508
2023-11-17 2023-11-15 S Sale
2.6
Zhen Marianne

Chief Accounting Officer

Officer
5,589 -10.9%
14.01
US$78,302 		5,589 -10.9% 14.01 US$78,302
2023-06-20 2023-06-15 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
62,000 +0.9%
13.13
US$814,196 		62,000 +0.9% 13.13 US$814,196
2023-06-07 2023-06-06 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
8,000 +0.1%
13.05
US$104,384 		8,000 +0.1% 13.05 US$104,384
2023-06-07 2023-06-05 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
7,000 +0.1%
13.04
US$91,297 		7,000 +0.1% 13.04 US$91,297
2023-05-30 2023-05-30 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
120,000 +1.7%
13.01
US$1,560,648 		120,000 +1.7% 13.01 US$1,560,648
2023-05-30 2023-05-26 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
30,000 +0.4%
13.12
US$393,729 		30,000 +0.4% 13.12 US$393,729
2023-05-30 2023-05-25 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
50,000 +0.7%
13.09
US$654,330 		50,000 +0.7% 13.09 US$654,330
2023-05-19 2023-05-18 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
10,000 +0.1%
13.05
US$130,538 		10,000 +0.1% 13.05 US$130,538
2023-05-19 2023-05-17 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
50,000 +0.7%
13.07
US$653,690 		50,000 +0.7% 13.07 US$653,690
2023-05-15 2023-05-11 B Purchase
2.8
DENNER ALEXANDER J
Large shareholder
290,000 +4.4%
12.34
US$3,577,411 		290,000 +4.4% 12.34 US$3,577,411
2023-03-14 2023-03-10 PP Planned purchase
Raifeld Pavel

Chief Executive Officer

Officer
3,000 +44.1%
10.87
US$32,603 		3,000 +44.1% 10.87 US$32,603
2021-05-25 2021-05-24 B Purchase
2.9
Bickerstaff George
Non-Executive Director
10,000 +8.7%
13.46
US$134,619 		10,000 +8.7% 13.46 US$134,619
2021-05-25 2021-05-21 B Purchase
2.9
Bickerstaff George
Non-Executive Director
10,000 +9.6%
12.97
US$129,670 		10,000 +9.6% 12.97 US$129,670
2021-05-24 2021-05-20 S Sale
2.3
GLAXOSMITHKLINE PLC
Large shareholder
32,005,260 -100.0%
12.25
US$392,064,435 		32,005,260 -100.0% 12.25 US$392,064,435
2020-02-24 2020-02-24 S Sale
2.6
Zhen Marianne

Chief Accounting Officer

Officer
2,954 -11.9%
14.78
US$43,660 		2,954 -11.9% 14.78 US$43,660
2019-02-28 2019-02-27 B Purchase
2.9
Bickerstaff George
Non-Executive Director
15,000 +38.7%
15.90
US$238,500 		15,000 +38.7% 15.90 US$238,500
2019-02-28 2019-02-26 S Sale
2.6
Zhen Marianne

Chief Accounting Officer

Officer
5,617 -23.1%
16.00
US$89,872 		5,617 -23.1% 16.00 US$89,872
2019-02-22 2019-02-21 B Purchase
2.9
Bickerstaff George
Non-Executive Director
10,000 +34.8%
14.90
US$148,958 		10,000 +34.8% 14.90 US$148,958
2019-02-20 2019-02-15 B Purchase
1.5
HULME GEOFFREY

Interim PEO

Officer
7,000 +inf%
14.80
US$103,600 		7,000 +inf% 14.80 US$103,600
2018-08-22 2018-08-21 PlS Planned sale ABERCROMBIE GEORGE B

Sr. VP & Chief Comm. Officer

Officer
8,000 -2.7%
14.11
US$112,840 		8,000 -2.7% 14.11 US$112,840
2018-08-22 2018-08-21 S Sale Witek Theodore J. Jr.

Sr. VP & Chief Scientific Off.

Officer
8,504 -3.3%
14.12
US$120,080 		8,504 -3.3% 14.12 US$120,080
2018-05-22 2018-05-21 PlS Planned sale ABERCROMBIE GEORGE B

Sr. VP & Chief Comm. Officer

Officer
8,000 -2.6%
14.40
US$115,202 		8,000 -2.6% 14.40 US$115,202
2018-05-22 2018-05-21 PlS Planned sale dEsparbes Eric

SVP and CFO

Officer
5,808 -1.5%
14.40
US$83,623 		5,808 -1.5% 14.40 US$83,623
2018-02-22 2018-02-21 PlS Planned sale Witek Theodore J. Jr.

Sr. VP & Chief Scientific Off.

Officer
9,890 -5.0%
16.60
US$164,148 		9,890 -5.0% 16.60 US$164,148
2018-02-22 2018-02-21 PlS Planned sale ABERCROMBIE GEORGE B

Sr. VP & Chief Comm. Officer

Officer
8,000 -3.3%
16.51
US$132,100 		8,000 -3.3% 16.51 US$132,100
2018-02-22 2018-02-21 PlS Planned sale dEsparbes Eric

Interim PEO, SVP and CFO

Officer
5,378 -1.8%
16.52
US$88,825 		5,378 -1.8% 16.52 US$88,825
2017-12-05 2017-12-04 S Sale Aguiar Michael W

President & Chief Exec Officer

Executive Director
12,022 -1.2%
13.13
US$157,791 		12,022 -1.2% 13.13 US$157,791
2017-11-22 2017-11-21 PlS Planned sale Witek Theodore J. Jr.

Sr. VP & Chief Scientific Off.
13,000 -5.7%
13.29
US$172,795 		13,000 -5.7% 13.29 US$172,795
2017-11-22 2017-11-21 PlS Planned sale ABERCROMBIE GEORGE B

Sr. VP & Chief Comm. Officer
5,215 -2.0%
13.26
US$69,145 		5,215 -2.0% 13.26 US$69,145
2017-11-22 2017-11-21 PlS Planned sale dEsparbes Eric

SVP and CFO
13,460 -4.0%
13.31
US$179,171 		13,460 -4.0% 13.31 US$179,171
2017-11-22 2017-11-20 PlS Planned sale dEsparbes Eric

SVP and CFO
1,825 -0.5%
13.04
US$23,798 		1,825 -0.5% 13.04 US$23,798
2017-08-22 2017-08-21 PlS Planned sale dEsparbes Eric

SVP and CFO
1,825 -0.5%
12.20
US$22,265 		1,825 -0.5% 12.20 US$22,265
2017-05-23 2017-05-22 PlS Planned sale Witek Theodore J. Jr.

Sr. VP & Chief Scientific Off.

Officer
7,815 -3.1%
12.01
US$93,858 		7,815 -3.1% 12.01 US$93,858
2017-05-23 2017-05-22 PlS Planned sale dEsparbes Eric

SVP and CFO

Officer
1,825 -0.5%
11.85
US$21,626 		1,825 -0.5% 11.85 US$21,626
2017-02-22 2017-02-21 PlS Planned sale dEsparbes Eric

SVP and CFO

Officer
1,825 -0.5%
12.07
US$22,028 		1,825 -0.5% 12.07 US$22,028
2016-11-22 2016-11-22 PlS Planned sale WITEK THEODORE L JR

Sr. VP & Chief Scientific Off.

Officer
3,700 -2.4%
10.84
US$40,123 		3,700 -2.4% 10.84 US$40,123
2016-11-22 2016-11-21 PlS Planned sale dEsparbes Eric

SVP and CFO

Officer
1,800 -0.8%
10.89
US$19,602 		1,800 -0.8% 10.89 US$19,602
2016-08-23 2016-08-22 PlS Planned sale dEsparbes Eric

SVP and CFO

Officer
3,700 -1.5%
11.77
US$43,549 		3,700 -1.5% 11.77 US$43,549
2016-05-20 2016-05-18 PlS Planned sale Tyree James L Non-Executive Director
813 -1.6%
10.47
US$8,512 		813 -1.6% 10.47 US$8,512
2015-05-29 2015-05-27 S Sale WALTRIP WILLIAM H Non-Executive Director
16,313 -11.7%
16.32
US$266,228 		16,313 -11.7% 16.32 US$266,228
2014-08-15 2014-08-13 S Sale LEE JUNNING

Sr. VP, Technical Operations

Officer
53,424 -16.8%
22.50
US$1,202,040 		53,424 -16.8% 22.50 US$1,202,040
2014-08-13 2014-08-12 S Sale Shafer Bradford J

Sr VP, Gen. Counsel, Secretary

Officer
1,048 -0.2%
22.30
US$23,370 		1,048 -0.2% 22.30 US$23,370
2014-08-13 2014-08-11 S Sale Shafer Bradford J

Sr VP, Gen. Counsel, Secretary

Officer
27,108 -5.7%
22.12
US$599,629 		27,108 -5.7% 22.12 US$599,629
2014-03-05 2014-03-03 PlS Planned sale Shafer Bradford J

Sr VP, Gen. Counsel, Secretary

Officer
1,800 -0.5%
37.23
US$67,014 		1,800 -0.5% 37.23 US$67,014
2014-03-05 2014-03-03 PlS Planned sale Shafer Bradford J

Sr VP, Gen. Counsel, Secretary

Officer
64,006 -16.3%
36.72
US$2,350,300 		64,006 -16.3% 36.72 US$2,350,300
2014-02-19 2014-02-14 PlS Planned sale Mammen Mathai

SVP, Research & Early Clin Dev

Officer
4,600 -2.4%
40.04
US$184,184 		4,600 -2.4% 40.04 US$184,184
2013-06-11 2013-06-07 S Sale Shafer Bradford J

Sr VP, Gen. Counsel, Secretary

Officer
31,038 -9.3%
35.04
US$1,087,572 		31,038 -9.3% 35.04 US$1,087,572
2013-05-15 2013-05-13 PlS Planned sale Brinkley David L

Head of Business Dev.

Officer
16,129 -22.7%
40.33
US$650,483 		16,129 -22.7% 40.33 US$650,483
2013-05-07 2013-05-03 PlS Planned sale Brinkley David L

Head of Business Dev.

Officer
16,129 -22.7%
34.77
US$560,805 		16,129 -22.7% 34.77 US$560,805
2013-05-02 2013-04-30 PlS Planned sale Mammen Mathai

SVP, Research & Early Clin Dev

Officer
200 -0.1%
34.34
US$6,868 		200 -0.1% 34.34 US$6,868
2013-05-02 2013-04-30 PlS Planned sale Brinkley David L

Head of Business Dev.

Officer
100 -0.2%
34.35
US$3,435 		100 -0.2% 34.35 US$3,435
2013-05-02 2013-04-30 PlS Planned sale Brinkley David L

Head of Business Dev.

Officer
17,004 -23.6%
33.76
US$574,055 		17,004 -23.6% 33.76 US$574,055
2013-05-02 2013-04-30 PlS Planned sale Aguiar Michael W

Sr VP, Chief Financial Officer

Officer
10,100 -6.6%
34.34
US$346,834 		10,100 -6.6% 34.34 US$346,834
2013-05-02 2013-04-30 PlS Planned sale Aguiar Michael W

Sr VP, Chief Financial Officer

Officer
160,779 -51.3%
33.77
US$5,429,507 		160,779 -51.3% 33.77 US$5,429,507
2013-05-02 2013-04-30 PlS Planned sale Winningham Rick E

Chief Executive Officer

Executive Director
1,577 -0.2%
34.32
US$54,123 		1,577 -0.2% 34.32 US$54,123
2013-05-02 2013-04-30 PlS Planned sale Winningham Rick E

Chief Executive Officer

Executive Director
253,955 -26.0%
33.64
US$8,543,046 		253,955 -26.0% 33.64 US$8,543,046
2013-02-22 2013-02-20 PlS Planned sale Mammen Mathai

SVP, Research & Early Clin Dev

Officer
7,000 -3.2%
22.14
US$154,980 		7,000 -3.2% 22.14 US$154,980
2012-11-06 2012-11-02 PlS Planned sale Mammen Mathai

SVP, Research & Early Clin Dev

Officer
200 -0.1%
22.53
US$4,506 		200 -0.1% 22.53 US$4,506
2012-08-28 2012-08-27 PlS Planned sale Aguiar Michael W

Sr VP, Chief Financial Officer

Officer
2,861 -2.1%
27.86
US$79,707 		2,861 -2.1% 27.86 US$79,707
2012-08-28 2012-08-27 PlS Planned sale Aguiar Michael W

Sr VP, Chief Financial Officer

Officer
17,700 -11.6%
27.24
US$482,148 		17,700 -11.6% 27.24 US$482,148
2012-08-28 2012-08-24 PlS Planned sale Aguiar Michael W

Sr VP, Chief Financial Officer

Officer
4,121 -2.6%
28.01
US$115,429 		4,121 -2.6% 28.01 US$115,429
2012-08-15 2012-08-13 PlS Planned sale Mammen Mathai

SVP, Research & Early Clin Dev

Officer
3,108 -1.4%
26.15
US$81,274 		3,108 -1.4% 26.15 US$81,274
2012-08-09 2012-08-07 PlS Planned sale Aguiar Michael W

Sr VP, Chief Financial Officer

Officer
60,000 -27.5%
27.04
US$1,622,400 		60,000 -27.5% 27.04 US$1,622,400
2012-08-07 2012-08-03 PlS Planned sale Brinkley David L

Head of Business Dev.

Officer
123,917 -65.0%
27.92
US$3,459,763 		123,917 -65.0% 27.92 US$3,459,763
2012-08-07 2012-08-03 PlS Planned sale Winningham Rick E

Chief Executive Officer

Executive Director
36,200 -5.8%
28.15
US$1,019,030 		36,200 -5.8% 28.15 US$1,019,030
2012-08-07 2012-08-03 PlS Planned sale Winningham Rick E

Chief Executive Officer

Executive Director
39,549 -5.9%
27.77
US$1,098,276 		39,549 -5.9% 27.77 US$1,098,276
2012-05-31 2012-05-29 S Sale Aguiar Michael W

Sr VP, Chief Financial Officer

Officer
20,000 -11.2%
22.29
US$445,800 		20,000 -11.2% 22.29 US$445,800
2012-05-16 2012-05-16 B Purchase GLAXOSMITHKLINE PLC Large shareholder
10,000,000 +63.2%
21.29
US$212,887,000 		10,000,000 +63.2% 21.29 US$212,887,000
2012-05-02 2012-05-01 S Sale DRAZAN JEFFREY M Non-Executive Director
8,586 -20.4%
21.71
US$186,402 		8,586 -20.4% 21.71 US$186,402
2011-12-13 2011-12-09 S Sale Aguiar Michael W

Sr VP, Chief Financial Officer

Officer
10,000 -5.1%
21.86
US$218,600 		10,000 -5.1% 21.86 US$218,600
2011-11-30 2011-11-28 PlS Planned sale Shafer Bradford J

Sr VP, Gen. Counsel, Secretary

Officer
20,000 -5.4%
21.00
US$420,000 		20,000 -5.4% 21.00 US$420,000
Explore more

More insider trading research around Innoviva Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America